TWM
GSK icon

Thrive Wealth Management’s GSK GSK Stock Holding History

Thrive Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316K Hold
6,031
– – 0.04% 185
2026
Q1 		$333K Sell
6,031
-412
-6% -$22.3K 0.05% 164
2025
Q4 		$316K Buy
6,443
+295
+5% +$13.8K 0.05% 170
2025
Q3 		$265K Sell
6,148
-2,929
-32% -$114K 0.04% 198
2025
Q2 		$349K Sell
9,077
-63
-0.7% -$2.41K 0.06% 160
2025
Q1 		$354K Buy
9,140
+1,891
+26% +$69.2K 0.07% 146
2024
Q4 		$245K Sell
7,249
-4,487
-38% -$162K 0.04% 172
2024
Q3 		$480K Buy
11,736
+124
+1% +$5.07K 0.09% 119
2024
Q2 		$447K Sell
11,612
-30
-0.3% -$1.26K 0.09% 117
2024
Q1 		$499K Buy
11,642
+2,198
+23% +$90.6K 0.1% 106
2023
Q4 		$350K Sell
9,444
-1,507
-14% -$54.1K 0.08% 128
2023
Q3 		$397K Buy
10,951
+254
+2% +$9.02K 0.11% 105
2023
Q2 		$381K Sell
10,697
-1,312
-11% -$47.1K 0.1% 114
2023
Q1 		$427K Buy
12,009
+1,379
+13% +$48.2K 0.11% 111
2022
Q4 		$374K Buy
10,630
+336
+3% +$11.2K 0.11% 110
2022
Q3 		$303K Sell
10,294
-402
-4% -$15.2K 0.11% 116
2022
Q2 		$582K Buy
10,696
+6,455
+152% +$356K 0.2% 67
2022
Q1 		$231K Buy
+4,241
New +$230K 0.07% 141

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
AWAG
ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return

Thrive Wealth Management's GSK Position: Q2 2026 in Review

Thrive Wealth Management held its GSK (GSK) position steady in Q2 2026 at 6,031 shares worth $316K. The position accounts for 0.04% of the portfolio, ranked #185.

Thrive Wealth Management first reported a position in GSK in Q1 2022 and has held it in 18 quarters since. The position peaked at $582K in Q2 2022. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Thrive Wealth Management held 6,031 shares of GSK worth $316K as of Q2 2026.
  • Thrive Wealth Management left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.04% of Thrive Wealth Management's portfolio in Q2 2026, its #185 holding.
  • Thrive Wealth Management first reported a position in GSK in Q1 2022 and has held it in 18 quarters since.
  • Thrive Wealth Management's GSK position peaked at $582K in Q2 2022.
  • 161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Thrive Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.